A nationwide survey of public COPD knowledge and awareness in Saudi Arabia: A population-based survey of 15,000 adults.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
04
2023
accepted:
05
06
2023
medline:
7
7
2023
pubmed:
5
7
2023
entrez:
5
7
2023
Statut:
epublish
Résumé
There is a concerning lack of representative data on chronic obstructive pulmonary disease (COPD) awareness in Saudi Arabia, and a significant proportion of the population is vulnerable to developing a smoking habit, which is a major risk factor for the disease. Population-Based Survey of 15,000 people was conducted to assess the public knowledge and awareness of COPD across Saudi Arabia from October 2022 to March 2023. A total of 15002 responders completed the survey, with a completion rate of 82%. The majority 10314 (69%) were 18-30 year and 6112 (41%) had high school education. The most common comorbidities among the responders were depression (7.67%); hypertension (6%); diabetes (5.77%) and Chronic Lung Disease (4.12%). The most common symptoms were dyspnea (17.80%); chest tightness (14.09%) and sputum (11.19%). Among those who complains of any symptoms, only 16.44% had consulted their doctor. Around 14.16% were diagnosed with a respiratory disease and only 15.56% had performed pulmonary function test (PFT). The prevalence of smoking history was 15.16%, in which current smokers were 9.09%. About 48% of smokers used cigarette, 25% used waterpipe and around 27% were E-cigarette users. About 77% of the total sample have never heard about COPD. Majority of current smokers (73.5%; 1002), ex-smokers (68%; 619), and non-smokers (77.9%; 9911) are unaware of COPD, p value <0.001. Seventy five percent (1028) of the current smokers and 70% (633) of the ex-smokers have never performed PFT, p value <0.001. Male, younger age (18-30 years), higher education, family history of respiratory diseases, previous diagnosis of respiratory disease, previous PFT, and being an ex-smokers increases the odds of COPD awareness, p-value <0.05. There is a significantly low awareness about COPD in Saudi Arabia, especially among smokers. A nationwide approach must include targeted public awareness campaigns, continued healthcare professional education, community-based activities encouraging diagnosis and early detection, advice on smoking cessation and lifestyle changes, as well as coordinated national COPD screening programs.
Sections du résumé
BACKGROUND
There is a concerning lack of representative data on chronic obstructive pulmonary disease (COPD) awareness in Saudi Arabia, and a significant proportion of the population is vulnerable to developing a smoking habit, which is a major risk factor for the disease.
METHODS
Population-Based Survey of 15,000 people was conducted to assess the public knowledge and awareness of COPD across Saudi Arabia from October 2022 to March 2023.
RESULTS
A total of 15002 responders completed the survey, with a completion rate of 82%. The majority 10314 (69%) were 18-30 year and 6112 (41%) had high school education. The most common comorbidities among the responders were depression (7.67%); hypertension (6%); diabetes (5.77%) and Chronic Lung Disease (4.12%). The most common symptoms were dyspnea (17.80%); chest tightness (14.09%) and sputum (11.19%). Among those who complains of any symptoms, only 16.44% had consulted their doctor. Around 14.16% were diagnosed with a respiratory disease and only 15.56% had performed pulmonary function test (PFT). The prevalence of smoking history was 15.16%, in which current smokers were 9.09%. About 48% of smokers used cigarette, 25% used waterpipe and around 27% were E-cigarette users. About 77% of the total sample have never heard about COPD. Majority of current smokers (73.5%; 1002), ex-smokers (68%; 619), and non-smokers (77.9%; 9911) are unaware of COPD, p value <0.001. Seventy five percent (1028) of the current smokers and 70% (633) of the ex-smokers have never performed PFT, p value <0.001. Male, younger age (18-30 years), higher education, family history of respiratory diseases, previous diagnosis of respiratory disease, previous PFT, and being an ex-smokers increases the odds of COPD awareness, p-value <0.05.
CONCLUSION
There is a significantly low awareness about COPD in Saudi Arabia, especially among smokers. A nationwide approach must include targeted public awareness campaigns, continued healthcare professional education, community-based activities encouraging diagnosis and early detection, advice on smoking cessation and lifestyle changes, as well as coordinated national COPD screening programs.
Identifiants
pubmed: 37406018
doi: 10.1371/journal.pone.0287565
pii: PONE-D-23-10282
pmc: PMC10321629
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0287565Informations de copyright
Copyright: © 2023 Alqahtani et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Healthcare (Basel). 2023 Jan 30;11(3):
pubmed: 36766964
BMC Pulm Med. 2022 Jul 28;22(1):289
pubmed: 35902833
Saudi J Anaesth. 2017 May;11(Suppl 1):S80-S89
pubmed: 28616007
BMJ Open. 2023 May 8;13(5):e069670
pubmed: 37156583
Respir Med. 2018 Sep;142:48-52
pubmed: 30170801
J Thorac Dis. 2014 Feb;6(2):161-8
pubmed: 24605232
Eur Respir J. 2006 Dec;28(6):1245-57
pubmed: 17138679
N Engl J Med. 2015 Jul 9;373(2):111-22
pubmed: 26154786
J Clin Med. 2023 Feb 25;12(5):
pubmed: 36902630
Ann Saudi Med. 2011 Mar-Apr;31(2):129-33
pubmed: 21403413
NPJ Prim Care Respir Med. 2021 Feb 11;31(1):6
pubmed: 33574323
Ann Thorac Med. 2021 Oct-Dec;16(4):299-305
pubmed: 34820017
Saudi Med J. 2014 Jul;35(7):684-90
pubmed: 25028224
Clin Respir J. 2007 Dec;1(2):118-9
pubmed: 20298291
NPJ Prim Care Respir Med. 2021 May 4;31(1):20
pubmed: 33947866
Psychol Med. 1998 May;28(3):551-8
pubmed: 9626712
Rev Mal Respir. 2009 May;26(5):521-9
pubmed: 19543171
Healthcare (Basel). 2022 Dec 18;10(12):
pubmed: 36554093
Lancet Respir Med. 2020 Jun;8(6):585-596
pubmed: 32526187
Eur Respir J. 2023 Apr 1;61(4):
pubmed: 36858443
Turk Thorac J. 2017 Oct;18(4):100
pubmed: 29404171
Int J Chron Obstruct Pulmon Dis. 2021 Oct 07;16:2769-2781
pubmed: 34675502
Chronic Dis Transl Med. 2022 Sep 17;8(4):322-330
pubmed: 36420173
Curr Opin Support Palliat Care. 2022 Dec 1;16(4):210-215
pubmed: 36102933
Lancet Respir Med. 2023 Jan;11(1):18
pubmed: 36462509
Chest. 2001 May;119(5):1365-70
pubmed: 11348940
Ann Thorac Med. 2018 Jul-Sep;13(3):144-149
pubmed: 30123332
Respir Med. 2007 Mar;101(3):525-30
pubmed: 16908127
Lancet Respir Med. 2021 Aug;9(8):824-826
pubmed: 34000234
Adv Exp Med Biol. 2021;1337:299-305
pubmed: 34972917
Arch Bronconeumol. 2012 Sep;48(9):308-15
pubmed: 22748482
BMC Pulm Med. 2023 Feb 2;23(1):49
pubmed: 36726097
Lancet Respir Med. 2017 Sep;5(9):691-706
pubmed: 28822787
Intern Med. 2015;54(2):163-9
pubmed: 25743007
BMJ Open Respir Res. 2022 Aug;9(1):
pubmed: 35944944
Korean J Intern Med. 2015 Mar;30(2):191-7
pubmed: 25750560
J Aerosol Med Pulm Drug Deliv. 2020 Aug;33(4):171-177
pubmed: 32423274
Yonsei Med J. 2015 Mar;56(2):362-7
pubmed: 25683982
Int J Chron Obstruct Pulmon Dis. 2023 Jan 09;18:23-35
pubmed: 36644218
Respirology. 2016 Jan;21(1):14-23
pubmed: 26494423
Prim Care Respir J. 2007 Feb;16(1):41-8
pubmed: 17297526
Int J Environ Res Public Health. 2022 Oct 06;19(19):
pubmed: 36232114
BMJ Open. 2022 Oct 27;12(10):e063900
pubmed: 36302583
PLoS One. 2022 May 19;17(5):e0268772
pubmed: 35588429
BMC Pulm Med. 2021 Nov 27;21(1):388
pubmed: 34837978
Int J Chron Obstruct Pulmon Dis. 2020 May 19;15:1103-1110
pubmed: 32546998
BMJ. 2004 May 29;328(7451):1312-5
pubmed: 15166072
Curr Med Res Opin. 2013 Aug;29(8):957-66
pubmed: 23663130